|
5ECH
Crystal Structure of FIN219-FIP1 complex with JA and ATP
Deposited 2015-10-20
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–217(217 aa)
Chain C
1–217(217 aa)
|
Not recorded
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
Resolution 2.14 Å
R-free 0.180
|
|
5ECH
Crystal Structure of FIN219-FIP1 complex with JA and ATP
Deposited 2015-10-20
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain E
1–217(217 aa)
Chain F
1–217(217 aa)
|
Not recorded
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
Resolution 2.14 Å
R-free 0.180
|
|
5ECI
Crystal Structure of FIN219-FIP1 complex with JA, ATP and Mg
Deposited 2015-10-20
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–217(217 aa)
Chain C
1–217(217 aa)
|
Not recorded
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
Resolution 1.56 Å
R-free 0.225
|
|
5ECI
Crystal Structure of FIN219-FIP1 complex with JA, ATP and Mg
Deposited 2015-10-20
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain E
1–217(217 aa)
Chain F
1–217(217 aa)
|
Not recorded
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
Resolution 1.56 Å
R-free 0.225
|
|
5ECK
Crystal Structure of FIN219-FIP1 complex with JA, Ile and ATP
Deposited 2015-10-20
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–217(217 aa)
Chain C
1–217(217 aa)
|
Not recorded
|
ILE ISOLEUCINE × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
Resolution 1.54 Å
R-free 0.175
|
|
5ECK
Crystal Structure of FIN219-FIP1 complex with JA, Ile and ATP
Deposited 2015-10-20
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain E
1–217(217 aa)
Chain F
1–217(217 aa)
|
Not recorded
|
ILE ISOLEUCINE × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
Resolution 1.54 Å
R-free 0.175
|
|
5ECL
Crystal Structure of FIN219-FIP1 complex with JA, Ile and Mg
Deposited 2015-10-20
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–217(217 aa)
Chain C
1–217(217 aa)
|
Not recorded
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
ILE ISOLEUCINE × 1
MG MAGNESIUM ION × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
Resolution 1.85 Å
R-free 0.219
|
|
5ECL
Crystal Structure of FIN219-FIP1 complex with JA, Ile and Mg
Deposited 2015-10-20
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain E
1–217(217 aa)
Chain F
1–217(217 aa)
|
Not recorded
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
ILE ISOLEUCINE × 1
MG MAGNESIUM ION × 3
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
Resolution 1.85 Å
R-free 0.219
|
|
5ECM
Crystal Structure of FIN219-FIP1 complex with JA and Leu
Deposited 2015-10-20
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–217(217 aa)
Chain C
1–217(217 aa)
|
Not recorded
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
LEU LEUCINE × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
Resolution 1.60 Å
R-free 0.245
|
|
5ECM
Crystal Structure of FIN219-FIP1 complex with JA and Leu
Deposited 2015-10-20
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain E
1–217(217 aa)
Chain F
1–217(217 aa)
|
Not recorded
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
LEU LEUCINE × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
Resolution 1.60 Å
R-free 0.245
|
|
5ECO
Crystal Structure of FIN219-FIP1 complex with JA, Leu and Mg
Deposited 2015-10-20
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–217(217 aa)
Chain C
1–217(217 aa)
|
Not recorded
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
LEU LEUCINE × 1
MG MAGNESIUM ION × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
Resolution 1.80 Å
R-free 0.239
|
|
5ECO
Crystal Structure of FIN219-FIP1 complex with JA, Leu and Mg
Deposited 2015-10-20
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain E
1–217(217 aa)
Chain F
1–217(217 aa)
|
Not recorded
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
LEU LEUCINE × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
Resolution 1.80 Å
R-free 0.239
|
|
5ECP
Crystal Structure of FIN219-FIP1 complex with JA, MET and ATP
Deposited 2015-10-20
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–217(217 aa)
Chain C
1–217(217 aa)
|
Not recorded
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
MET METHIONINE × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
Resolution 2.25 Å
R-free 0.208
|
|
5ECP
Crystal Structure of FIN219-FIP1 complex with JA, MET and ATP
Deposited 2015-10-20
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain E
1–217(217 aa)
Chain F
1–217(217 aa)
|
Not recorded
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
MET METHIONINE × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
Resolution 2.25 Å
R-free 0.208
|
|
5ECQ
Crystal Structure of FIN219-FIP1 complex with JA, VAL and ATP
Deposited 2015-10-20
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–217(217 aa)
Chain C
1–217(217 aa)
|
Not recorded
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
VAL VALINE × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
Resolution 1.66 Å
R-free 0.234
|
|
5ECQ
Crystal Structure of FIN219-FIP1 complex with JA, VAL and ATP
Deposited 2015-10-20
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain E
1–217(217 aa)
Chain F
1–217(217 aa)
|
Not recorded
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
VAL VALINE × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
Resolution 1.66 Å
R-free 0.234
|
|
5ECR
Crystal Structure of FIN219-FIP1 complex with JA, VAL and Mg
Deposited 2015-10-20
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–217(217 aa)
Chain C
1–217(217 aa)
|
Not recorded
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
VAL VALINE × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
Resolution 1.72 Å
R-free 0.281
|
|
5ECR
Crystal Structure of FIN219-FIP1 complex with JA, VAL and Mg
Deposited 2015-10-20
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain E
1–217(217 aa)
Chain F
1–217(217 aa)
|
Not recorded
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
VAL VALINE × 1
GSH Glutathione × 2
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
Resolution 1.72 Å
R-free 0.281
|
|
5ECS
Crystal Structure of FIP1 with GSH
Deposited 2015-10-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–217(217 aa)
|
Not recorded
|
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
Resolution 1.65 Å
R-free 0.188
|
|
5ECS
Crystal Structure of FIP1 with GSH
Deposited 2015-10-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–217(217 aa)
|
Not recorded
|
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
Resolution 1.65 Å
R-free 0.188
|